JAK2/IDH-mutant-driven myeloproliferative neoplasm is sensitive to combined targeted inhibition
JAK2/IDH突变驱动的骨髓增生性肿瘤对联合靶向抑制疗法敏感
期刊:Journal of Clinical Investigation
影响因子:13.6
doi:10.1172/JCI124920
McKenney, Anna Sophia; Lau, Allison N; Somasundara, Amritha Varshini Hanasoge; Spitzer, Barbara; Intlekofer, Andrew M; Ahn, Jihae; Shank, Kaitlyn; Rapaport, Franck T; Patel, Minal A; Papalexi, Efthymia; Shih, Alan H; Chiu, April; Freinkman, Elizaveta; Akbay, Esra A; Steadman, Mya; Nagaraja, Raj; Yen, Katharine; Teruya-Feldstein, Julie; Wong, Kwok-Kin; Rampal, Raajit; Vander Heiden, Matthew G; Thompson, Craig B; Levine, Ross L